odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet
- RxCUI
- 2563983
- RxNorm name
- odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet
- Display name
- odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet
- Full name
- odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BYLVAY | ODEVIXIBAT | Albireo Pharma, Inc. | 151f1d3e-2bf4-47ce-b1be-a892de3258fa | 2025-12-31 | Warnings, Adverse reactions | 2563983 |
| Bylvay | ODEVIXIBAT | Ipsen Biopharmaceuticals, Inc. | 0935cd31-3251-4a0a-ac23-25ca4be12be9 | 2025-12-29 | Warnings, Adverse reactions | 2563983 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 151f1d3e-2bf4-47ce-b1be-a892de3258fa | odevixibat 200 MCG Oral Pellet [PSN] · odevixibat 0.2 MG Oral Pellet [SCD] · odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet [SY] · odevixibat 200 MCG Oral Pellet [SY] | 4 | 9 | These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | 20251231 |
| 0935cd31-3251-4a0a-ac23-25ca4be12be9 | odevixibat 200 MCG Oral Pellet [PSN] · odevixibat 0.2 MG Oral Pellet [SCD] · odevixibat (as odevixibat sesquihydrate) 200 MCG Oral Pellet [SY] · odevixibat 200 MCG Oral Pellet [SY] | 4 | 4 | These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | 20251229 |